Project Details
Description
Expanded Access Program for Aztreonamn Lysine for Inhalation in Patients with Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection who have Limited Treatment Options and are at Risk for Disease Progression
| Status | Finished |
|---|---|
| Effective start/end date | 1/15/08 → 12/31/10 |
Funding
- GILEAD SCIENCES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.